Correction to: A Multicentric Clinical Study to Evaluate Pharmacokinetics, Efficacy, and Safety of Immune Globulin Subcutaneous 20% Weekly/Biweekly Dosing in Treatment-Experienced Patients and Loading/Weekly Maintenance Dosing in Treatment-Naïve Patients with Primary Immunodeficiency

Affiliations

• ¹ Allergy and Asthma Research Association Research Center, 10100 N. Central Expressway, Suite 100, TX, 75231, Dallas, USA. Lumrymd@aararesearch.com.
• ² Allergy & Clinical Immunology Associates, Pittsburgh, PA, USA.
• ³ Allergy & Immunology, Research Solutions of Arizona, Litchfield, AZ, USA.
• ⁴ Allergy, Asthma & Immunology Center, Vital Prospects Clinical Research Institute, Tulsa, OK, USA.
• ⁵ Optimed Research Ltd, Columbus, OH, USA.
• ⁶ Allergy & Asthma Clinics of Georgia, Georgia Pollens Clinical Research Centers, Albany, GA, USA.
• ⁷ Washington University School of Medicine, Saint Louis, MO, USA.
• ⁸ Institute for Asthma and Allergy, Chevy Chase, MD, USA.
• ⁹ Grifols Scientific Innovation Office, Research Triangle Park, NC, USA.
• ¹⁰ Grifols Scientific Innovation Office, Sant Cugat, Spain.